+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 6epp | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | RAS GUANINE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) AND FRAGMENT SCREENING HIT F4 | ||||||
要素 |
| ||||||
キーワード | SIGNALING PROTEIN / Guanine nucleotide exchange factor / GEF / Fragment Screen / GTPASE | ||||||
| 機能・相同性 | 機能・相同性情報midbrain morphogenesis / regulation of pro-B cell differentiation / vitellogenesis / pericardium morphogenesis / cardiac atrium morphogenesis / heart trabecula morphogenesis / regulation of T cell differentiation in thymus / GTPase complex / Interleukin-15 signaling / positive regulation of small GTPase mediated signal transduction ...midbrain morphogenesis / regulation of pro-B cell differentiation / vitellogenesis / pericardium morphogenesis / cardiac atrium morphogenesis / heart trabecula morphogenesis / regulation of T cell differentiation in thymus / GTPase complex / Interleukin-15 signaling / positive regulation of small GTPase mediated signal transduction / Activation of RAC1 / blood vessel morphogenesis / Signaling by LTK / epidermal growth factor receptor binding / Regulation of KIT signaling / positive regulation of epidermal growth factor receptor signaling pathway / response to mineralocorticoid / GMP binding / forebrain astrocyte development / leukocyte migration / LRR domain binding / NRAGE signals death through JNK / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / neurotrophin TRK receptor signaling pathway / response to gravity / epithelial tube branching involved in lung morphogenesis / Fc-epsilon receptor signaling pathway / type I pneumocyte differentiation / eyelid development in camera-type eye / Rac protein signal transduction / GRB2:SOS provides linkage to MAPK signaling for Integrins / roof of mouth development / regulation of T cell proliferation / B cell homeostasis / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / RET signaling / myoblast proliferation / skeletal muscle cell differentiation / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / positive regulation of glial cell proliferation / SOS-mediated signalling / fibroblast growth factor receptor signaling pathway / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / Role of LAT2/NTAL/LAB on calcium mobilization / SHC1 events in ERBB4 signaling / Interleukin receptor SHC signaling / hair follicle development / cardiac muscle cell proliferation / Signalling to RAS / Signal attenuation / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Schwann cell development / Estrogen-stimulated signaling through PRKCZ / glial cell proliferation / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / FRS-mediated FGFR3 signaling / Signaling by CSF3 (G-CSF) / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / FRS-mediated FGFR1 signaling / p38MAPK events / Signaling by FGFR3 in disease / protein-membrane adaptor activity / Tie2 Signaling / striated muscle cell differentiation / Signaling by FGFR2 in disease / RAC1 GTPase cycle / myelination / GRB2 events in EGFR signaling / Signaling by FLT3 fusion proteins / SHC1 events in EGFR signaling / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / FCERI mediated Ca+2 mobilization / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / homeostasis of number of cells within a tissue / Downstream signal transduction / GRB2 events in ERBB2 signaling / insulin-like growth factor receptor signaling pathway / Insulin receptor signalling cascade 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / シンクロトロン / フーリエ合成 / 解像度: 2.4 Å | ||||||
データ登録者 | Hillig, R.C. / Moosmayer, D. / Hilpmann, A. / Bader, B. / Schroeder, J. / Wortmann, L. / Sautier, B. / Kahmann, J. / Wegener, D. / Briem, H. ...Hillig, R.C. / Moosmayer, D. / Hilpmann, A. / Bader, B. / Schroeder, J. / Wortmann, L. / Sautier, B. / Kahmann, J. / Wegener, D. / Briem, H. / Petersen, K. / Badock, V. | ||||||
引用 | ジャーナル: Proc. Natl. Acad. Sci. U.S.A. / 年: 2019タイトル: Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction. 著者: Hillig, R.C. / Sautier, B. / Schroeder, J. / Moosmayer, D. / Hilpmann, A. / Stegmann, C.M. / Werbeck, N.D. / Briem, H. / Boemer, U. / Weiske, J. / Badock, V. / Mastouri, J. / Petersen, K. / ...著者: Hillig, R.C. / Sautier, B. / Schroeder, J. / Moosmayer, D. / Hilpmann, A. / Stegmann, C.M. / Werbeck, N.D. / Briem, H. / Boemer, U. / Weiske, J. / Badock, V. / Mastouri, J. / Petersen, K. / Siemeister, G. / Kahmann, J.D. / Wegener, D. / Bohnke, N. / Eis, K. / Graham, K. / Wortmann, L. / von Nussbaum, F. / Bader, B. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 6epp.cif.gz | 281.8 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb6epp.ent.gz | 226.9 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 6epp.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 6epp_validation.pdf.gz | 730.4 KB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 6epp_full_validation.pdf.gz | 735 KB | 表示 | |
| XML形式データ | 6epp_validation.xml.gz | 26.4 KB | 表示 | |
| CIF形式データ | 6epp_validation.cif.gz | 38.7 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ep/6epp ftp://data.pdbj.org/pub/pdb/validation_reports/ep/6epp | HTTPS FTP |
-関連構造データ
| 関連構造データ | ![]() 5ovdC ![]() 5oveC ![]() 5ovfC ![]() 5ovgC ![]() 5ovhC ![]() 5oviC ![]() 6eieC ![]() 6eplC ![]() 6epmC ![]() 6epnC ![]() 6epoC ![]() 1bkdS C: 同じ文献を引用 ( S: 精密化の開始モデル |
|---|---|
| 類似構造データ |
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 19386.850 Da / 分子数: 1 / 変異: G12C, C118S, D126E, T127S, K128R / 由来タイプ: 組換発現 / 詳細: N-terminal G is a cloning artifact / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: KRAS, KRAS2, RASK2 / 発現宿主: ![]() |
|---|---|
| #2: タンパク質 | 分子量: 57103.285 Da / 分子数: 1 / 変異: K563G / 由来タイプ: 組換発現 / 詳細: Mutation K563G is a cloning artifact / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: SOS1 / 発現宿主: ![]() |
| #3: 化合物 | ChemComp-GOL / |
| #4: 化合物 | ChemComp-BOQ / |
| #5: 水 | ChemComp-HOH / |
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 3.68 Å3/Da / 溶媒含有率: 66.6 % |
|---|---|
| 結晶化 | 温度: 277 K / 手法: 蒸気拡散法, ハンギングドロップ法 詳細: Drops made from KRAS SOS1 complex (14.4 mg/ml in 5 mM Tris pH 7.5, 100mM NaCl) and reservoir solution (2.9 to 3.4 M sodium formate, 100 mM MES pH 6.5). Fragment soaked at 25 mM for three days ...詳細: Drops made from KRAS SOS1 complex (14.4 mg/ml in 5 mM Tris pH 7.5, 100mM NaCl) and reservoir solution (2.9 to 3.4 M sodium formate, 100 mM MES pH 6.5). Fragment soaked at 25 mM for three days at 277 K using a 500 mM fragment stock solution in DMSO. Cryo buffer 0.1 M MES pH 6.5, 3.5 M sodium formate, 20 glycerol, 25 mM fragment |
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: ESRF / ビームライン: ID29 / 波長: 0.9762 Å |
| 検出器 | タイプ: DECTRIS PILATUS 6M-F / 検出器: PIXEL / 日付: 2014年7月9日 |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 0.9762 Å / 相対比: 1 |
| 反射 | 解像度: 2.4→47.43 Å / Num. obs: 44844 / % possible obs: 99.9 % / 冗長度: 9.5 % / Biso Wilson estimate: 47.3 Å2 / CC1/2: 0.998 / Rrim(I) all: 0.113 / Net I/av σ(I): 17.4 / Net I/σ(I): 17.4 |
| 反射 シェル | 解像度: 2.4→2.54 Å / 冗長度: 9.7 % / Mean I/σ(I) obs: 2.5 / Num. unique obs: 7124 / CC1/2: 0.895 / Rrim(I) all: 0.845 / % possible all: 99.9 |
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: フーリエ合成開始モデル: 1BKD 解像度: 2.4→47.43 Å / Cor.coef. Fo:Fc: 0.961 / Cor.coef. Fo:Fc free: 0.955 / SU B: 11.549 / SU ML: 0.132 / 交差検証法: THROUGHOUT / ESU R: 0.225 / ESU R Free: 0.176 / 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 53.999 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: 1 / 解像度: 2.4→47.43 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
引用





















PDBj




























